Regeneron Pharmaceuticals (REGN) Operating Income Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.10% |
| Dec 31, 2025 | -8.45% |
| Sep 30, 2025 | -5.68% |
| Jun 30, 2025 | -0.92% |
| Mar 31, 2025 | -22.24% |
| Dec 31, 2024 | -27.88% |
| Sep 30, 2024 | -13.89% |
| Jun 30, 2024 | -31.63% |
| Mar 31, 2024 | -12.27% |
| Dec 31, 2023 | -5.88% |
| Sep 30, 2023 | 1.80% |
| Jun 30, 2023 | 15.69% |
| Mar 31, 2023 | 10.58% |
| Dec 31, 2022 | 19.28% |
| Sep 30, 2022 | 18.33% |
| Jun 30, 2022 | 52.07% |
| Mar 31, 2022 | 37.89% |
| Dec 31, 2021 | 54.33% |
| Sep 30, 2021 | 43.36% |
| Jun 30, 2021 | 75.22% |
| Mar 31, 2021 | 25.18% |
| Dec 31, 2020 | 29.38% |
| Sep 30, 2020 | 23.44% |
| Jun 30, 2020 | 6.05% |
| Mar 31, 2020 | 17.59% |
| Dec 31, 2019 | 24.88% |
| Sep 30, 2019 | 26.73% |
| Jun 30, 2019 | 2.67% |
| Mar 31, 2019 | 13.38% |
| Dec 31, 2018 | 45.93% |
| Sep 30, 2018 | 16.90% |
| Jun 30, 2018 | 21.74% |
| Mar 31, 2018 | 26.00% |
| Dec 31, 2017 | 29.63% |
| Sep 30, 2017 | 43.76% |
| Jun 30, 2017 | 34.12% |
| Mar 31, 2017 | 30.99% |
| Dec 31, 2016 | 21.16% |
| Sep 30, 2016 | 15.28% |
| Jun 30, 2016 | 22.64% |
| Mar 31, 2016 | 29.10% |
| Dec 31, 2015 | 16.63% |
| Sep 30, 2015 | 24.70% |
| Jun 30, 2015 | 57.97% |
| Mar 31, 2015 | 133.75% |
| Dec 31, 2014 | 95.29% |
| Sep 30, 2014 | 73.51% |
| Jun 30, 2014 | 79.48% |
| Mar 31, 2014 | 88.28% |
| Dec 31, 2013 | 158.48% |
| Sep 30, 2013 | 110.88% |
| Jun 30, 2013 | 105.39% |
| Mar 31, 2013 | 93.99% |
| Dec 31, 2012 | 78.59% |
| Sep 30, 2012 | 441.47% |
| Jun 30, 2012 | 94.68% |